Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.
Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, Zhao N, Wang YH, Behr SC, Korkola JE, Evans MJ, Collisson EA, Renslo AR.
Jiang H, et al. Among authors: hann bc.
J Exp Med. 2022 Apr 4;219(4):e20210739. doi: 10.1084/jem.20210739. Epub 2022 Mar 9.
J Exp Med. 2022.
PMID: 35262628
Free PMC article.